Abstract Major depressive disorders affect the general health and reduce the life quality. The treatments approaches are used to treat major depressive disorders are counselling and antidepressant medication. Due to occurrence of serious but low adverse events, there is essential need to design and develop new drug with lesser toxic and higher potency. In this work, we performed the evaluation of pharmacokinetic descriptors, bioactivity score and various types of toxicities through computational methods.